Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1050 of 3173 entries
View as:

Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13®

Phase: N/A Priority: Normal
NCT ID: NCT01392378 Org: User:
Start: 08/31/11 End: 01/31/13 Due: 01/31/14

Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.

Phase: N/A Priority: Normal
NCT ID: NCT03269695 Org: User:
Start: 12/20/17 End: 01/07/21 Due: 01/07/22

Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers

Phase: N/A Priority: Normal
NCT ID: NCT00527150 Org: User:
Start: 10/31/07 End: 02/29/08 Due: 02/28/09

Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00480636 Org: User:
Start: 06/30/07 End: 06/30/09 Due: 06/30/10

Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT01652885 Org: User:
Start: 07/31/12 End: 11/30/12 Due: 11/30/13

Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury

Phase: N/A Priority: Normal
NCT ID: NCT00555009 Org: User:
Start: 03/31/08 End: 01/31/09 Due: 01/31/10

Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00639483 Org: User:
Start: 03/31/03 End: 01/31/04 Due: 01/31/05

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01849874 Org: User:
Start: 06/27/13 End: 08/23/22 Due: 08/23/23

A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.

Phase: N/A Priority: Normal
NCT ID: NCT03776175 Org: User:
Start: 01/04/19 End: 10/11/19 Due: 10/11/20

Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00279448 Org: User:
Start: 01/31/02 End: 06/30/09 Due: 06/30/10

Post Marketing Surveillance Study on Linezolid

Phase: N/A Priority: Normal
NCT ID: NCT01564758 Org: User:
Start: 02/29/04 End: 03/31/05 Due: 03/31/06

A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin

Phase: N/A Priority: Normal
NCT ID: NCT00990613 Org: User:
Start: 10/31/09 End: 01/31/10 Due: 01/31/11

A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01637285 Org: User:
Start: 08/31/12 End: 01/31/13 Due: 01/31/14

Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.

Phase: N/A Priority: Normal
NCT ID: NCT01339962 Org: User:
Start: 04/30/11 End: 04/30/12 Due: 04/30/13

Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01664923 Org: User:
Start: 08/31/12 End: 01/31/18 Due: 01/31/19

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05703607 Org: User:
Start: 01/25/23 End: 08/20/30 Due: 08/20/31

Safety and Efficacy of Xalkori ROS1

Phase: N/A Priority: Normal
NCT ID: NCT03375242 Org: User:
Start: 10/25/17 End: 03/26/27 Due: 03/26/28

A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US

Phase: N/A Priority: Normal
NCT ID: NCT06504524 Org: User:
Start: 09/01/23 End: 05/31/24 Due: 05/31/25

Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing

Phase: N/A Priority: Normal
NCT ID: NCT05059522 Org: User:
Start: 09/29/21 End: 09/30/26 Due: 09/30/27

A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06994897 Org: User:
Start: 06/30/25 End: 09/18/26 Due: 09/18/27

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

Phase: N/A Priority: Normal
NCT ID: NCT06616194 Org: User:
Start: 11/15/24 End: 12/02/27 Due: 12/02/28

Clinical Outcome Of Hormonal Receptor Positive, Her-2 Negative Breast Cancer In Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT02924584 Org: User:
Start: 02/01/17 End: 04/30/18 Due: 04/30/19

A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06580938 Org: User:
Start: 11/11/24 End: 10/15/25 Due: 10/15/26

RN624 In Adult Patients With Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT00584870 Org: User:
Start: 07/05/07 End: 09/02/08 Due: 09/02/09

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03685591 Org: User:
Start: 10/04/18 End: 03/30/22 Due: 03/30/23